ARTICLE | Product Development
Biocircuits goes for speed over perfection
March 7, 1994 8:00 AM UTC
Opting for speed to market over perfection, Biocircuits Corp. has decided to reformulate the method used in its assay to measure thyroid dysfunction. Investors reacted with dismay, trimming 45 percent off BIOC shares, which closed Friday at $2.25.
The Sunnyvale, Calif., company 's ultimate goal is to produce point-of-care diagnostics that don't need reagents. However, the company ran into problems achieving accurate reproducibility in the naturally fluorescent membrane that was to be used in the assay cartridge. The planning configuration was designed to measure how much fluorescence was turned off in the presence of antigen or antibody...